| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. | Director | Stock Option (right to buy) | 17,500 | 02 Jun 2025 | Direct | ||
| Atreca, Inc. | Director | Stock Option (right to buy) | 12,000 | 13 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | 02 Jun 2025 | 1 | $0 | 4 | Director | 03 Jun 2025, 16:10 |
| ORKA | Oruka Therapeutics, Inc. | 29 Aug 2024 | 0 | $0 | 3 | Director | 06 Sep 2024, 17:04 |
| /report/000120919123037515-ball-kristine-m-2023-06-13 | Atreca, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:02 |
| /report/000120919122036109-ball-kristine-m-2022-06-08 | Atreca, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 18:47 |
| /report/000120919121039850-ball-kristine-m-2021-06-09 | Atreca, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 16:35 |